TSPYL4
Testis-specific Y-encoded-like protein 4
Also known as: dJ486I3.2, KIAA0721, TSYL4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UJ04
- Gene
- TSPYL4
- Ensembl
- ENSG00000187189
- Chromosome
- 6
- Canonical length
- 414 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable chromatin binding activity and histone binding activity. Predicted to be involved in nucleosome assembly. Predicted to be active in chromatin and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
414 residues, UniProt reviewed canonical sequence.
>Q9UJ04|TSPYL4
1 MSGLDGGNKL PLAQTGGLAA PDHASGDPDR DQCQGLREET EATQVMANTG GGSLETVAEG
61 GASQDPVDCG PALRVPVAGS RGGAATKAGQ EDAPPSTKGL EAASAAEAAD SSQKNGCQLG
121 EPRGPAGQKA LEACGAGGLG SQMIPGKKAK EVTTKKRAIS AAVEKEGEAG AAMEEKKVVQ
181 KEKKVAGGVK EETRPRAPKI NNCMDSLEAI DQELSNVNAQ ADRAFLQLER KFGRMRRLHM
241 QRRSFIIQNI PGFWVTAFRN HPQLSPMISG QDEDMLRYMI NLEVEELKHP RAGCKFKFIF
301 QGNPYFRNEG LVKEYERRSS GRVVSLSTPI RWHRGQDPQA HIHRNREGNT IPSFFNWFSD
361 HSLLEFDRIA EIIKGELWPN PLQYYLMGEG PRRGIRGPPR QPVESARSFR FQSGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSPYL4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 89 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 89 nTPM
- cerebral cortex: 75 nTPM
- hypothalamus: 69 nTPM
- basal ganglia: 66 nTPM
- amygdala: 47 nTPM
- hippocampal formation: 47 nTPM
Single-cell type
- parietal cells: 58 nCPM
- corticotrophs: 53 nCPM
- adrenal medulla cells: 43 nCPM
- other brain neurons: 40 nCPM
- esophageal apical cells: 40 nCPM
- fallopian tube ciliated cells: 38 nCPM
Immune cell
- naive CD4 T-cell: 4.1 nTPM
- total PBMC: 4 nTPM
- memory CD4 T-cell: 3.9 nTPM
- MAIT T-cell: 3.8 nTPM
- NK-cell: 3.8 nTPM
- T-reg: 3.7 nTPM
Brain region
- hypothalamus: 167 nTPM
- cerebral cortex: 166 nTPM
- pons: 142 nTPM
- basal ganglia: 141 nTPM
- midbrain: 133 nTPM
- cerebellum: 130 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.74
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
InteractionsUniProt · HPA
Protein binding partners of TSPYL4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSPYL4 as an antibody target. Whether an autoantibody or antibody against TSPYL4 could matter depends on whether native TSPYL4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSPYL4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TSPYL4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...